These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7637595)

  • 21. [Vaccines today and tomorrow].
    Stenbeck J; Iwarson S
    Lakartidningen; 1989 May; 86(22):2126-8. PubMed ID: 2543871
    [No Abstract]   [Full Text] [Related]  

  • 22. Japanese encephalitis in a U.S. traveler returning from Thailand, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(5):123-5. PubMed ID: 15703694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advice for travelers.
    Med Lett Drugs Ther; 1998 Apr; 40(1025):47-50. PubMed ID: 9590982
    [No Abstract]   [Full Text] [Related]  

  • 24. [Unauthorized vaccines put on the market are useful for certain travelers].
    Chippaux A
    Bull Soc Pathol Exot; 1997; 90(4):240-2. PubMed ID: 9479460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vaccination against Japanese encephalitis in not justified].
    Niklasson P
    Lakartidningen; 1988 Nov; 85(45):3815. PubMed ID: 2846974
    [No Abstract]   [Full Text] [Related]  

  • 26. Japanese encephalitis for a reference to international travelers.
    Oya A; Kurane I
    J Travel Med; 2007; 14(4):259-68. PubMed ID: 17617849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Japanese encephalitis].
    Jelinek T
    Dtsch Med Wochenschr; 2002 May; 127(21):1155-6. PubMed ID: 12085312
    [No Abstract]   [Full Text] [Related]  

  • 28. Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy.
    Wierzba TF; Ghimire P; Malla S; Banerjee MK; Shrestha S; Khanal B; Sedai TR; Gibbons RV
    Am J Trop Med Hyg; 2008 Jun; 78(6):1002-6. PubMed ID: 18541784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader?
    Caramello P; Canta F; Balbiano R; Lipani F; Ariaudo S; De Agostini M; Calleri G; Boglione L; Di Caro A
    J Travel Med; 2007; 14(5):346-8. PubMed ID: 17883468
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of the distribution of host species on adult abundance of Japanese encephalitis vectors Culex vishnui subgroup and Culex gelidus in a rice-cultivating village in northern Vietnam.
    Hasegawa M; Tuno N; Yen NT; Nam VS; Takagi M
    Am J Trop Med Hyg; 2008 Jan; 78(1):159-68. PubMed ID: 18187800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Japanese encephalitis and dengue vaccines.
    Barrett AD
    Biologicals; 1997 Mar; 25(1):27-34. PubMed ID: 9167006
    [No Abstract]   [Full Text] [Related]  

  • 32. [Japanese encephalitis].
    Jackson Y; Chappuis F; Loutan L
    Rev Med Suisse; 2007 May; 3(111):1233-6. PubMed ID: 17585626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Japanese encephalitis: development of new candidate vaccines.
    Bharati K; Vrati S
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Japanese encephalitis: is there a need for a novel vaccine?
    Wilder-Smith A; Freedman DO
    Expert Rev Vaccines; 2009 Aug; 8(8):969-72. PubMed ID: 19627179
    [No Abstract]   [Full Text] [Related]  

  • 35. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IC51: a new investigational Japanese encephalitis vaccine. Dr Christoph Klade speaks to Duc Le, editor.
    Klade CS
    Expert Rev Vaccines; 2008 Oct; 7(8):1139-40. PubMed ID: 18844587
    [No Abstract]   [Full Text] [Related]  

  • 37. Intradermal boosting of Japanese encephalitis vaccination.
    Kitchener S; Baade L; Brennan L; Nasveld P
    J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistent Japanese encephalitis in Kathmandu: the need for immunization.
    Basnyat B; Zimmerman MD; Shrestha Y; Scott RM; Endy TP
    J Travel Med; 2001; 8(5):270-1. PubMed ID: 11703912
    [No Abstract]   [Full Text] [Related]  

  • 39. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should vaccination be a priority approach for Japanese encephalitis prevention in Nepal?
    Joshi AB; Banjara MR; Wierzba T
    JNMA J Nepal Med Assoc; 2005; 44(157):31. PubMed ID: 16152681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.